European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Francesco Panzuto¹, John Ramage², D Mark Pritchard³, Marie-Louise F van Velthuysen⁴, Joerg Schrader⁵, Nehara Begum⁶, Anders Sundin⁷, Massimo Falconi⁸, Dermot O'Toole⁹

Affiliations

¹ Department of Medical-Surgical Sciences and Translational Medicine, Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
² Department of Gastroenterology, Hampshire Hospitals and ENETS Center, Kings Health Partners London, London, United Kingdom.
³ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
⁴ Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁵ Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁶ Department for General-, Visceral-, Thoracic- and Endocrine Surgery, Johannes-Wesling-Klinikum Minden, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
⁷ Department of Surgical Sciences, Radiology & Molecular Imaging, Uppsala University, Uppsala, Sweden.
⁸ Pancreas Translational and Clinical Research Center, Pancreatic Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁹ National Centre for Neuroendocrine Tumours, ENETS Centre of Excellence, St. Vincent's University Hospital, Dublin, Ireland.

PMID: 37401795
DOI: 10.1111/jne.13306

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Francesco Panzuto et al. J Neuroendocrinol. 2023 Aug.

. 2023 Aug;35(8):e13306.

doi: 10.1111/jne.13306. Epub 2023 Jul 4.

Authors

Francesco Panzuto¹, John Ramage², D Mark Pritchard³, Marie-Louise F van Velthuysen⁴, Joerg Schrader⁵, Nehara Begum⁶, Anders Sundin⁷, Massimo Falconi⁸, Dermot O'Toole⁹

Affiliations

¹ Department of Medical-Surgical Sciences and Translational Medicine, Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
² Department of Gastroenterology, Hampshire Hospitals and ENETS Center, Kings Health Partners London, London, United Kingdom.
³ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
⁴ Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁵ Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁶ Department for General-, Visceral-, Thoracic- and Endocrine Surgery, Johannes-Wesling-Klinikum Minden, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
⁷ Department of Surgical Sciences, Radiology & Molecular Imaging, Uppsala University, Uppsala, Sweden.
⁸ Pancreas Translational and Clinical Research Center, Pancreatic Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁹ National Centre for Neuroendocrine Tumours, ENETS Centre of Excellence, St. Vincent's University Hospital, Dublin, Ireland.

PMID: 37401795
DOI: 10.1111/jne.13306

Abstract

The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.

Keywords: duodenal neuroendocrine tumours; gastric carcinoids; guidelines; management; prognosis.

PubMed Disclaimer

References

REFERENCES

1. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335-1342. doi:10.1001/jamaoncol.2017.0589
1. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104(4):994-1006. doi:10.1016/0016-5085(93)90266-f
1. Sato Y, Iwafuchi M, Ueki J, et al. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci. 2002;47(3):579-585.
1. Fossmark R, Calvete O, Mjønes P, Benitez J, Waldum HL. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit. APMIS. 2016;124(7):561-566. doi:10.1111/apm.12546
1. Trinh VQ, Shi C, Ma C. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis. Histopathology. 2020;77(6):865-876. doi:10.1111/his.14220

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Affiliations

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Authors

Affiliations

Abstract

References

REFERENCES

MeSH terms

LinkOut - more resources

Full Text Sources

Medical